GSK reports positive outcomes from Phase III multiple myeloma treatment trial
GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab ...
Robert F. Kennedy Jr: Trump's biggest anti-establishment bombshell?
President-elect Donald Trump has selected Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of ...
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide.
Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his ...
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to ...
FTSE 100 Live 15 November: GDP setback, Land Securities upbeat but index falls
Jitters over the health of the UK economy have been fuelled by today’s weaker-than-expected GDP release. September’s 0.1% ...
Business Recorder43m
Europe’s STOXX 600 opens lower as tech, healthcare shares drag
Europe’s STOXX 600 opened lower on Friday, dragged by technology and healthcare stocks, keeping the index on track for its ...
Pharmaceutical Technology46m
Trump picks vaccine sceptic RFK Jr to lead HHS in new administration
If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal agencies that dictate healthcare policy in ...
Spero Therapeutics, Inc.: Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into mid-2026; Q3 2024 ending cash balance of $76.3M CAMBRIDGE, Mass., Nov. 14 ...